| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -4,850 | -172 |
| Depreciation and amortization | 18 | 12 |
| Write-off of intangible assets | 174 | 174 |
| Share based compensation | 40 | 6 |
| Change in fair value of convertible loans and warrant liability and financial expenses, net | -3,680 | 314 |
| Financial expenses, net | 8 | 10 |
| Other expenses | 445 | - |
| Other accounts receivables | 10 | -8 |
| Inventory | 40 | 32 |
| Accounts payable | 12 | 11 |
| Accounts payables related party | 173 | 84 |
| Net cash used in operating activities | -350 | -213 |
| Research and development expenses capitalization | - | 1 |
| Net cash used in investing activities | - | -1 |
| Proceeds from issuance of common stock | 735 | 124 |
| Net cash provided by financing activities | 735 | 124 |
| Foreign exchange on cash and cash equivalents | 4 | 19 |
| Change in cash and cash equivalents | 389 | -71 |
| Cash and cash equivalents at beginning of period | 79 | - |
| Cash and cash equivalents at end of period | 468 | - |
APPYEA, INC (APYP)
APPYEA, INC (APYP)